Search
for
Sort by
Research 871–900 of 1000+
- The connection of 5-alpha reductase inhibitors to the development of depression
- No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study
- The GPI-Anchored Protein Thy-1/CD90 Promotes Wound Healing upon Injury to the Skin by Enhancing Skin Perfusion
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- A Natural Inhibitor, 1′S-1′-Acetoxychavicol Acetate, Against Testosterone-Induced Alopecia via NADPH Oxidase Regulation
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Under Development JAK Inhibitors for Dermatologic Diseases
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease
- The Hair Growth-Promoting Effect of<i>Rumex japonicus</i>Houtt. Extract
- miR-370-3p Inhibited the Proliferation of Sheep Dermal Papilla Cells by Inhibiting the Expression of SMAD4
- Acne
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Cucurbitacin promotes hair growth in mice by inhibiting the expression of fibroblast growth factor 18
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- Autologous Platelet-Rich Plasma Injection Therapy
- JAK inhibitors in dermatology: The promise of a new drug class
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- The Role of Thymosin Beta 4 on Odontogenic Differentiation in Human Dental Pulp Cells
- Novel Biodegradable Polymeric Microparticles Facilitate Scarless Wound Healing by Promoting Re-epithelialization and Inhibiting Fibrosis